Abesamis, Lilia D.

HRN: 01-19-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
CEFTRIAXONE 1G (VIAL)
12/25/2022
01/01/2023
IV
2grams
OD
Complicated UTI
Waiting Final Action 
01/06/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/06/2023
01/12/2023
IVT
1.5g
Q6 ANST
CAP MR
Waiting Final Action 
01/06/2023
CEFTAZIDIME 1GM (VIAL)
01/06/2023
01/12/2023
IVT
1g
Q8 ANST
CAP MR
Waiting Final Action 
01/10/2023
CEFIXIME 200MG (CAP)
01/10/2023
01/17/2023
ORAL
200 Mg
BID
CAP MR, Resolving
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: